Basics Liquidia Technologies, Inc. IPO Date: July 23, 2018 Sector: Healthcare Industry: Biotech Market Cap: $1.33B Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 3.42% Avg Daily Range (30 D): $0.47 | 3.03% Avg Daily Range (90 D): $0.38 | 2.59% Institutional Daily Volume Avg Daily Volume: .58M Avg Daily Volume (30 D): 1.48M Avg Daily Volume (90 D): 1.08M Trade Size Avg Trade Size (Sh.): 111 Avg Trade Size (Sh.) (30 D): 69 Avg Trade Size (Sh.) (90 D): 67 Institutional Trades Total Inst.Trades: 580 Avg Inst. Trade: $1.47M Avg Inst. Trade (30 D): $1.82M Avg Inst. Trade (90 D): $1.56M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.6M Avg Closing Trade (30 D): $2.16M Avg Closing Trade (90 D): $1.75M Avg Closing Volume: 149.4K         News May 23, 2025 @ 6:28 PM U.S. FDA Approves Liquidia’s YUTREPIAâ„Â... Source: Liquidia Corporation May 12, 2025 @ 10:00 AM Liquidia Corporation Provides Update on Litigation... Source: N/A May 2, 2025 @ 9:28 PM District Court Dismisses Dispute Filed by United T... Source: Liquidia Corporation Mar 12, 2025 @ 12:00 PM Liquidia Corporation to Report Full Year 2024 Fina... Source: N/A Feb 24, 2025 @ 12:00 PM Atea Pharmaceuticals Appoints Arthur S. Kirsch to ... Source: Globe Newswire Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.58 $-.45 $-.46 Diluted EPS $-1.58 $-.45 $-.46 Revenue $ 14.14M $ 3.12M $ 2.92M Gross Profit $ 8.22M $ 1.6M $ 1.56M Net Income / Loss $ -127.83M $ -38.37M $ -38.37M Operating Income / Loss $ -127.92M $ -35.43M $ -36.11M Cost of Revenue $ 5.93M $ 1.52M $ 1.35M Net Cash Flow $ 11.9M $ -6.72M $ -27.89M PE Ratio